Intensive lipid lowering with atorvastatin in patients with stable coronary disease - The New England Journal of Medicine - 2005

Brief Summary:

In patients with stable CAD and hyperlipidemia, atorvastatin 80 mg PO daily is associated with a greater reduction in CAD mortality, non-fatal MI not related to procedures, resuscitation after cardiac arrest, or fatal or nonfatal stroke when compared to atorvastatin 10 mg PO daily.